Immuron planned Acquisition of R&D Vaccine Company
MELBOURNE, Australia, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on...
Month: September 2021
Todos Medical Launches Tollovid Daily™ via Subscription at MyTollovid.com
Consumers can subscribe for an auto-shipped supply of Tollovid Daily™ 3CL protease inhibitor for immune support every month New York,...
SCYNEXIS to Present Data on Oral Ibrexafungerp at IDWeek 2021 from Interim Analyses of Phase 3 FURI Clinical Trial Showing Therapeutic Response Rates in Patients with Mucocutaneous and Invasive Fungal Infections
Analysis of subpopulations from a total of 74 patients evaluated to date from FURI includes outcomes by disease, bone and...
Surrozen Announces Appointment of Liz Nguyen as Vice President and Head of Human Resources
SOUTH SAN FRANCISCO, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Surrozen Inc. (Nasdaq: SRZN), a biotechnology company discovering and developing...
Scopus BioPharma to Present at the Benzinga Healthcare Small Cap Conference
Scopus to present on launch of Duet Therapeutics, its wholly-owned subsidiary focused on immuno-oncologyNEW YORK, Sept. 23, 2021 (GLOBE NEWSWIRE) --...
Ayala Pharmaceuticals Announces Publication Highlighting Clinical Activity of its Gamma Secretase Inhibitor AL101 in Desmoid Tumors
REHOVOT, Israel and WILMINGTON, Del., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company...
OraSure to Receive up to $13.6 Million from Biomedical Advanced Research Development Authority to Support InteliSwab™ COVID-19 Rapid Test 510(k) Clearance and CLIA Waiver
BETHLEHEM, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home...
Celldex Announces Upcoming Presentation of CDX-0159 Phase 1b Results in Inducible Urticaria at the 2021 European Academy of Dermatology and Venereology (EADV) 30th Congress
HAMPTON, N.J., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that an abstract describing symptom control...
Nexstim to Present at Redeye Medtech & Diagnostics Seminar
Press release, Helsinki, September 23, 2021 at 3 PM (EEST) Nexstim to Present at Redeye Medtech & Diagnostics Seminar Nexstim...
DLH Wins FEMA Contract for COVID-19 Emergency Medical Services Throughout Alaska
ATLANTA, Sept. 23, 2021 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of...
electroCore to Participate at Upcoming Investor Conferences
ROCKAWAY, NJ, Sept. 23, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today...
Novan Reports Safety Data from B-SIMPLE4 Pivotal Phase 3 Study of SB206
– SB206 demonstrates continued favorable safety profile consistent with previous studies and meets Company’s expectations – – Pre-NDA meeting with...
Gain Therapeutics to Present at the Cantor Virtual Global Healthcare Conference
Conference Dates: September 27th-30thBETHESDA, Md., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”),...
Soleno Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference
REDWOOD CITY, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing...
Frontier Medicines to Present at the Cantor Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock...
POINT Biopharma Announces Initiation of Randomization for its Phase 3 SPLASH study Evaluating PNT2002 for mCRPC
25 patient dosimetry and safety run-in met all pre-specified safety and efficacy criteria Initiated patient enrollment in Canada with additional...
Daré Bioscience Initiates Phase 1/2 Clinical Study of DARE-VVA1, Intravaginal Tamoxifen for the Treatment of Vulvar and Vaginal Atrophy
Investigational therapy for women who cannot, or should not, take supplemental estrogen Potential to be the first treatment for vulvar...
BriaCell Therapeutics CEO Emphasizes Recent Key Developments in Audio Interview with SmallCapVoice.com
BriaCell Therapeutics CEO Interview BriaCell Therapeutics CEO Emphasizes Recent Key Developments in Audio Interview with SmallCapVoice.com AUSTIN, Texas, Sept. 23,...
Nanox to Present at the Cantor Fitzgerald Global Healthcare Conference
NEVE ILAN, Israel, Sept. 23, 2021 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative...
TFF Pharmaceuticals Announces Promising Topline Results from Phase 1 Clinical Trial of Inhaled Tacrolimus Powder and Progression Toward Phase 2 in Lung Transplantation
Inhaled Tacrolimus Shows Dose-Dependent PK that Achieves Desired Therapeutic Plasma Concentrations and Promising Safety Profile in both SAD and MAD...
